Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Objective Evaluation of Collagen Deposition in AlloMaxTM Acellular Dermal Matrix in Breast Reconstruction Version 8-15-12

NCT01679223 is registered in ClinicalTrials.gov with University of Nevada, Las Vegas as lead sponsor.

NCT NCT01679223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01679223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Objective Evaluation of Collagen Deposition in AlloMaxTM Acellular Dermal Matrix in Breast Reconstruction Version 8-15-12
Lead sponsor
University of Nevada, Las Vegas
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2014
Completion date
November 30, 2018
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer